Projects per year
Abstract / Description of output
Immunosuppressants are clinically approved drugs to treat the potential rejection of transplanted organs and require frequent monitoring due to their narrow therapeutic window. Immunophilins are small proteins that bind immunosuppressants with high affinity, yet there are no examples of fluorogenic immunophilins and their potential application as optical biosensors for immunosuppressive drugs in clinical biosamples. In the present work, we designed novel diazonium BODIPY salts for the site-specific labeling of tyrosine residues in peptides via solid-phase synthesis as well as for late-stage functionalization of whole recombinant proteins. After the optimization of a straightforward one-step labeling procedure for immunophilins PPIA and FKBP12, we demonstrated the application of a fluorogenic analogue of FKBP12 for the selective detection of the immunosuppressant drug tacrolimus, including experiments in urine samples from patients with functioning renal transplants. This chemical methodology opens new avenues to rationally design wash-free immunophilin-based biosensors for rapid therapeutic drug monitoring.
Original language | English |
---|---|
Pages (from-to) | 969-977 |
Journal | ACS Central Science |
Volume | 10 |
Issue number | 5 |
Early online date | 18 Mar 2024 |
DOIs | |
Publication status | Published - 22 May 2024 |
Fingerprint
Dive into the research topics of 'Non-perturbative fluorogenic labeling of immunophilins enables wash-free detection of immunosuppressants'. Together they form a unique fingerprint.Projects
- 1 Finished